Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis

Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis

BackgroundIn multifactorial diseases, alterations in the concentration of metabolites can identify novel pathological mechanisms at the intersection between genetic and environmental influences. This study aimed to profile the plasma metabolome of patients with dementia with Lewy bodies (DLB) and Al...

Full description

Bibliographic Details
Main Authors: Xiaobei Pan, Paul C. Donaghy, Gemma Roberts, Leonidas Chouliaras, John T. O’Brien, Alan J. Thomas, Amanda J. Heslegrave, Henrik Zetterberg, Bernadette McGuinness, Anthony P. Passmore, Brian D. Green, Joseph P. M. Kane
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
dementia
Lewy body dementia
Alzheimer’s disease
metabolomic analyses
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1326780/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2023.1326780/full

Similar Items